170 related articles for article (PubMed ID: 33896816)
21. Sinomenine Can Inhibit the Growth and Invasion Ability of Retinoblastoma Cell through Regulating PI3K/AKT Signaling Pathway.
Zheng Q; Zhu Q; Li C; Hao S; Li J; Yu X; Qi D; Pan Y
Biol Pharm Bull; 2020 Oct; 43(10):1551-1555. PubMed ID: 32759601
[TBL] [Abstract][Full Text] [Related]
22. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
23. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
24. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.
Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S
Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656
[TBL] [Abstract][Full Text] [Related]
25. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.
Wang J; Wang S; Chen L; Tan J
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495818
[TBL] [Abstract][Full Text] [Related]
26. Osthole exhibits an antitumor effect in retinoblastoma through inhibiting the PI3K/AKT/mTOR pathway via regulating the hsa_circ_0007534/miR-214-3p axis.
Lv X; Yang H; Zhong H; He L; Wang L
Pharm Biol; 2022 Dec; 60(1):417-426. PubMed ID: 35175172
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of microRNA‑182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation.
Huang YX; Nie XG; Li GD; Fan DS; Song LL; Zhang XL
Int J Oncol; 2018 Dec; 53(6):2615-2626. PubMed ID: 30320366
[TBL] [Abstract][Full Text] [Related]
28. MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway.
Gui F; Hong Z; You Z; Wu H; Zhang Y
Cell Biol Int; 2016 Dec; 40(12):1294-1302. PubMed ID: 27600360
[TBL] [Abstract][Full Text] [Related]
29. Nesfatin-1 Promotes Proliferation, Migration and Invasion of HTR-8/SVneo Trophoblast Cells and Inhibits Oxidative Stress via Activation of PI3K/AKT/mTOR and AKT/GSK3β Pathway.
Li T; Wei S; Fan C; Tang D; Luo D
Reprod Sci; 2021 Feb; 28(2):550-561. PubMed ID: 32974855
[TBL] [Abstract][Full Text] [Related]
30. Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer.
Zhou W; Ma J; Meng L; Liu D; Chen J
BMC Cancer; 2022 Apr; 22(1):459. PubMed ID: 35473511
[TBL] [Abstract][Full Text] [Related]
31. Oncosuppressive functions of tribbles pseudokinase 3.
Salazar M; Lorente M; Orea-Soufi A; Dávila D; Erazo T; Lizcano J; Carracedo A; Kiss-Toth E; Velasco G
Biochem Soc Trans; 2015 Oct; 43(5):1122-6. PubMed ID: 26517935
[TBL] [Abstract][Full Text] [Related]
32. The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases.
Prudente S; Sesti G; Pandolfi A; Andreozzi F; Consoli A; Trischitta V
Endocr Rev; 2012 Aug; 33(4):526-46. PubMed ID: 22577090
[TBL] [Abstract][Full Text] [Related]
33. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
34. TRIB3 suppresses proliferation and invasion and promotes apoptosis of endometrial cancer cells by regulating the AKT signaling pathway.
Qu J; Liu B; Li B; Du G; Li Y; Wang J; He L; Wan X
Onco Targets Ther; 2019; 12():2235-2245. PubMed ID: 30988628
[TBL] [Abstract][Full Text] [Related]
35. Mammalian Pseudokinase TRIB3 in Normal Physiology and Disease: Charting the Progress in Old and New Avenues.
Ord T; Ord T
Curr Protein Pept Sci; 2017; 18(8):819-842. PubMed ID: 28393700
[TBL] [Abstract][Full Text] [Related]
36. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
37. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Fang D; Lai Z; Wang Y
Med Sci Monit; 2019 Sep; 25():6639-6648. PubMed ID: 31483776
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic pseudogene DUXAP10 knockdown suppresses proliferation and invasion and induces apoptosis of papillary thyroid carcinoma cells by inhibition of Akt/mTOR pathway.
Li J; Jiang L; Liu Z; Li Y; Xu Y; Liu H
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1473-1483. PubMed ID: 32215944
[TBL] [Abstract][Full Text] [Related]
40. TRIB3 inhibits proliferation and promotes osteogenesis in hBMSCs by regulating the ERK1/2 signaling pathway.
Zhang C; Hong FF; Wang CC; Li L; Chen JL; Liu F; Quan RF; Wang JF
Sci Rep; 2017 Sep; 7(1):10342. PubMed ID: 28871113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
